Trials / Terminated
TerminatedNCT00128115
Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
Proprietary Information - Exploratory (Non-Confirmatory) Trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate an improvement in physical functional recovery, following administration of Drug for 24 weeks, in patients who have recently experienced a hip fracture. This study will also evaluate the safety and tolerability of Drug. This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0677 |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2005-08-09
- Last updated
- 2016-01-20
Locations
5 sites across 5 countries: Germany, Norway, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00128115. Inclusion in this directory is not an endorsement.